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Streptococcus suis is an important cause of
meningitis, arthritis and septicaemia, especially
in young pigs. Serotype 2 is the most prevalent
type in clinical material from pigs in Europe
(Wisselink et al. 2000) and the infection causes
severe disease outbreaks in swine herds. Differ-
ent experimental models have been used to elu-
cidate the infection but central parts of the
pathogenesis still remain unclear (Gottschalk &
Segura 2000). In spontaneous infection, S. suis
is generally believed to invade via the upper
respiratory tract (Gottschalk & Segura 2000).
Recently, we described an infection model in
minipigs using aerogenous challenge and sub-
sequent steroid treatment (Madsen et al.
2001a). In conventional pigs, reports of models
attempting aerosol exposure seem limited to a
single study using anaesthetized pigs (Chen-
gappa et al. 1986). 
In order to evaluate the pathogenesis of S. suis
type 2 infection in pigs, we aimed at establish-
ing an aerosol model for the infection using
unanaesthetized conventionally reared, weaned
pigs. The present report describes the microbi-
ological and pathological ﬁndings in a pilot
study of an aerosol model for S. suis infection
in conventional pigs.
Four clinically healthy, 6-week-old, female,
Landrace-Yorkshire crossbred pigs (animals
A-D) from the same litter (weaned at app. 4
weeks of age) were included in this study. They
were obtained from a herd with no history of
disease compatible with S. suis infection and S.
suis had never been isolated from the herd. For
the aerosol exposure, a 1.5 m3 chamber con-
nected to a nebulizing apparatus was used. The
chamber and procedure used were essentially as
previously described (Madsen et al. 2001a).
Brieﬂy, the animals were in the chamber for 20
min while 40 ml of an aquatic solution of 1%
acetic acid (pH 3.4) was dispersed and let into
the chamber with atmospheric air. Then the
pigs were kept outside the chamber for one
hour. Thereafter, 3 of the animals (A-C) were
brought back into the chamber and 42.5 ml of a
bacterial suspension was dispersed over 20 min
in the air supply to the chamber. The bacterial
suspension was a 5-h broth culture of S. suis
serotype 2 (strain P321/6) concentrated to 1.1 ×
1010 colony-forming units/ml. The fourth pig
(D) served as a control to evaluate the immedi-
ate effect of acetic acid alone. One h after
exposure to acetic acid in the chamber, this an-
imal was euthanized by exsanguination after
being anaesthetized by intramuscular injection
(1 ml/15 kg) of Zoletil® (25 mg/ml zolezepam,
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Brief Communication25 mg/ml tiletamin). The 3 remaining animals
were housed in a single pen and observed for
clinical signs of disease and rectal temperatures
were recorded daily. On the ﬁfth day after ex-
posure, animal A was euthanized due to the
severity of clinical signs. The 2 remaining pigs
were euthanized on the sixth day.
Following euthanasia, all pigs were necropsied
and gross lesions were recorded. Tissues for
microscopy as well as swabs for microbiologi-
cal culturing were collected to cover all parts of
the respiratory tract and a range of organs
known to be affected in S. suis infection (Mad-
sen et al. 2001a). From each animal, samples
were taken from gross lesions as well as a stan-
dard of 31 tissues for histopathology and 18 tis-
sues for microbiological culture, which was
done aerobically at 37°C on 5% calf blood agar.
Morphologically suspect colonies were subcul-
tured and identiﬁed biochemically and serolog-
ically using standard methods. From aseptically
sampled blood as well as from areas with a nor-
mal bacterial ﬂora, i.e., nasal cavity, pharyngeal
and palatine tonsils, microbiological culture
was done as previously described (Madsen et
al. 2001a).
For histopathology, ﬁxation in 4% neutral
buffered formaldehyde, decalciﬁcation of rele-
vant tissues, as well as processing of HE stained
sections were performed as previously de-
scribed (Madsen et al. 1998). The presence of
S. suis antigen was examined by immunohisto-
chemistry using a previously published proto-
col (Madsen et al. 2001b). 
Clinical signs were only observed in pigs A and
C with onset on days 3 and 5 after exposure, re-
spectively. These pigs had loss of appetite, ele-
vated body temperatures (40.0-41.5°C), were
reluctant to rise and lame in one or more legs.
Gross lesions were noted in animal A, in which
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Table 1. Distribution of lesions and of S. suis serotype 2 as detected by culture and immunohistochemistry in
3 animals after aerosolic challenge.
Tissue Animals positive Characteristic macroscopic and/or histologic lesions (Animals)
Culture IHC
Nasal cavity C A,C Mild, focal mucopurulent rhinitis (A,C)
Lung - A Diffuse ﬁbrinopurulent pleuritis (A,B); acute embolic pneumonia (A)
Bronchial lnn. - A Follicular hyperplasia and exudation of heterophils (A,B)
Middle ear C B Unilateral purulent otitis media and exudate in Eustachian tube (B)
Inner ear n.d. C Bilateral purulent labyrinthitis and perineuritis (n. vestibularis) (C) -
Fig. 1
Tonsil, pharyngeal A,C C Focal exudation of heterophils (C)
Tonsil, soft palate A,B,C A,B,C Heterophils in crypt epithelium and lumen (A,B,C)
Brain C C Diffuse ﬁbrinopurulent meningitis with focal submeningeal 
encephalitis (C)
Heart A A Diffuse ﬁbrinopurulent pericarditis (A)
Peritoneum A A Diffuse ﬁbrinopurulent peritonitis (A)
Mesenteric lnn. - A Follicular hyperplasia and exudation of heterophils (A)
Liver A A Multifocal, subcapsular hepatic necrosis and ﬁbrinopurulent 
perihepatitis (A)
Spleen C A -
Joints A,C A,C Suppurative arthritis (A,C) 
Blood A n.d. -
n.d.: not done; -: negative; IHC: immunohistochemistry for S. suis serotype 2 ; A,B,C: animal no.a ﬁbrinopurulent polyserositis was seen, and in
animal C, which had an exudative meningitis
and arthritis.
By microscopy, a range of lesions of a generally
suppurative nature were noted in the challenged
animals (Table 1). Lesions compatible with
septicaemia were seen in animal A. In animal
C, the histopathological ﬁndings included sup-
purative meningitis, arthritis, and labyrinthitis
(Fig. 1). In the third S. suis exposed animal, B,
a suppurative otitis media was observed histo-
logically. In the control animal, D, the only
changes observed were focal, mild mucopuru-
lent rhinitis and focal, mild, chronic, purulent
bronchopneumonia in the right cranial lung
lobe.
By immunohistochemistry, S. suis serotype 2
antigen was demonstrated in animals A-C in a
number of tissues (Table 1). Generally, antigen
detection was related to the presence of 1-3 µm
structures, resembling coccoid bacteria, located
intracellularly or in exudates. Rarely, a more
diffuse intracellular immunostaining was ob-
served in phagocytes in inﬂamed tissues or cor-
responding lymphoid tissues. S. suis serotype 2
was reisolated from various tissues in animals
A, B, and C  (Table 1). No bacterial pathogens
were isolated from animal D.
The clinical signs as well as the lesions ob-
served in 2 of the 3 animals challenged with S.
suis were comparable to spontaneous S. suis
serotype 2 infection in pigs (Reams et al. 1994).
Acute embolic pneumonia was also observed in
animal A. Although this observation is not
common in S. suis infections, bacterial em-
bolism is not surprising given the bacteraemia
present. In animal C, a bilateral labyrinthitis
with S. suis antigen present in the exudate was
detected. This lesion, which apparently has not
been seen previously in experimental pig mod-
els of this infection, is a common sequela in
porcine meningitis due to spontaneous S. suis
serotype 2 infection (Madsen et al. 2001b).
Furthermore, hearing loss due to inner ear af-
fection is a major characteristic in humans af-
fected by S. suis meningitis (Arends & Zanen
1988). In animal B, otitis media with S. suis
antigen present was observed. As no signs of a
systemic infection were observed in this ani-
mal, these ﬁndings might constitute a local in-
fection after direct spread via the likewise af-
fected Eustachian tube.
In the control animal D, only minor lesions
were found. Thus, the observed focal bron-
chopneumonia is regarded as being insigniﬁ-
cant. However, the mucopurulent rhinitis also
seen in the infected animals may have been as-
sociated with the exposure to acetic acid. This
would be in concordance with previous studies,
where intranasal instillation of 1% acetic acid
was shown to induce loss of cilia and epithe-
lium as well as submucosal oedema and inﬂam-
mation within 12 h of exposure (Gagné & Mar-
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Figure 1. Inner ear, S. suis infected pig (animal C).
Suppurative labyrinthitis with exudate (arrow) in the
perilymph of the cochlear scala tympani. HE × 4.tineau-Doizé 1993). However, further studies
are required to evaluate the effect of exposure to
acetic acid and the interaction with S. suis in-
fection in this model.
In conclusion, by experimental aerosolic expo-
sure, infection with S. suis serotype 2 was es-
tablished in unanaesthetized conventional pigs,
and lesions similar to those seen in sponta-
neously infected animals were induced. 
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